Banagan, Merlita G.

HRN: 25-80-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
08/08/2025
08/15/2025
IV
500mg
OD
UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines